Since its initial public offering, ConvaTec has followed a familiar playbook to press its advantage in advanced wound care and to enhance its ostomy and continence care businesses. By and large ...

Convatec Group shares are rising nearly 7%. The company reported that its preliminary profit before income taxes for the year ended 31 December 2024 increased to $245.9 million from $167.4 million ...

At the time when OpenAI was making waves across the globe, India’s GenAI ecosystem was still very much in its infancy India is home to more than 200 GenAI startups and these startups have raised ...

Skin is the largest organ of human body, acting as a barrier with protective, immunologic and sensorial functions. Its permanent exposure to the external environment can result in different kinds ...

Tissue engineering has emerged as a new and promising field for the treatment of skin lesions, combining scaffolds, cells and biomolecular signals, such as growth factors. It is a ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

At close: March 14 at 6:45:57 PM GMT ...

There is no Morningstar’s Analysis data available.

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and ...